Asthma, COPD & Respiratory Disease Conditions (7)
Asthma, chronic obstructive pulmonary disease (COPD), pulmonary fibrosis, and airway inflammation.
40 Master Condition Specialty Hubs
Show All 40 Hubs ×Asthma, COPD & Respiratory Disease Guides (7)
Clear All Filters ×Secondhand Smoke
Secondhand smoke is a mixture of the smoke that comes from the burning end of a cigarette, cigar, or pipe, and the smoke breathed out by the smoker. It contains more than 7,000 chemicals. Hundreds of those chemicals are toxic and about 70 can cause cancer. Health effects of secondhand smoke include: Ear infections in children More frequent and severe asthma attacks in children Heart disease and lung cancer in adults who have never smoked There is no safe amount of secondhand smoke. Even low levels of it can be harmful. The only way to fully protect nonsmokers from secondhand smoke is not to allow smoking indoors. Centers for Disease Control and Prevention
Severe persistent asthma with (acute) exacerbation
Clinical triage of Severe persistent asthma with (acute) exacerbation (J45.51) in Lungs & Asthma relies on lung diffusion capacity in Severe persistent asthma with (acute) exacerbation (J45.51: (DLCO)), guiding step-wise therapeutic adjustments toward Resting Pulse Oximetry in Severe persistent asthma with (acute) exacerbation (J45.51: (SpO2)) (96% – 100% (J45.51)).
Severe persistent asthma with status asthmaticus
Physicians managing Severe persistent asthma with status asthmaticus (J45.52; Asthma, COPD & Respiratory Disease) utilize high-resolution chest imaging in Severe persistent asthma with status asthmaticus (J45.52: when indicated) and objective Spirometry FEV1 / in Severe persistent asthma with status asthmaticus (J45.52: FVC Ratio) targets (>= 0.75 (FEV1 >= 80% predicted) (J45.52)) to prevent progression and functional morbidity.
Severe persistent asthma, uncomplicated
Physicians managing Severe persistent asthma, uncomplicated (J45.50; Asthma, COPD & Respiratory Disease) utilize post-bronchodilator spirometry [Severe persistent asthma, uncomplicated J45.50] and objective Resting Pulse Oximetry in Severe persistent asthma, uncomplicated (J45.50: (SpO2)) targets (96% – 100% (J45.50)) to prevent progression and functional morbidity.
Shortness of breath (dyspnea)
Designated in federal medical registries as R06.00, Shortness of breath (dyspnea) (also termed Dyspnea or Short of breath) falls under Lungs & Asthma management, where vaccination review [Shortness of breath (dyspnea) R06.00] establishes baseline severity and rules out diagnostic mimics.
Silicosis
Cataloged under federal diagnostic code J62.8 in Lungs & Asthma, Silicosis requires vaccination review [Silicosis J62.8] so specialists can calibrate treatment intensity against Blood Eosinophil Count [Silicosis J62.8] benchmarks.
Surfactant mutations of the lung
Surfactant mutations of the lung—coded clinically as J84.83 across Lungs & Asthma guidelines—combines FeNO/eosinophil Type-2 inflammation in Surfactant mutations of the lung (J84.83: phenotyping) with structured follow-up of Resting Pulse Oximetry in Surfactant mutations of the lung (J84.83: (SpO2)) (96% – 100% (J84.83)).